Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence and the length of time it took to kill its victims, but these forms of plague ultimately died out.
A study by researchers at McMaster University and France’s Institut Pasteur, published in the journal Science, addresses some fundamental questions related to pandemics: how do they enter human populations, cause immense sickness, and evolve different levels of virulence to persist in populations?
The Black Death remains the single deadliest pandemic in recorded human history, killing an estimated 30–50% of the populations of Europe, Western Asia and Africa as it moved through those regions. Appearing in the 14th century, it re-emerged in waves over more than 500 years, persisting until 1840.
The Black Death was caused by the same bacteria which caused the Plague of Justinian, the first plague pandemic which had broken out in the mid-500s. The third plague pandemic began in China in 1855 and continues today. Its deadly effects are now more controlled by antibiotics but are still felt in regions like Madagascar and the Democratic Republic of Congo, where cases are regularly reported.
“This is one of the first research studies to directly examine changes in an ancient pathogen, one we still see today, in an attempt to understand what drives the virulence, persistence and/or eventual extinction of pandemics,” says Hendrik Poinar, co-senior author of the study, director of the McMaster Ancient DNA Center and holder of the Michael G. DeGroote Chair in Genetic Anthropology.
Strains of the Justinian plague became extinct after 300 years of ravaging European and Middle Eastern populations. Strains of the second pandemic emerged from infected rodent populations, causing the Black Death, before breaking into two major lineages. One of these two lineages is the ancestor of all present-day strains. The other re-emerged over centuries in Europe and ultimately went extinct by the early 19th century.
Using hundreds of samples from ancient and modern plague victims, the team screened for a gene known as pla, a high copy component of Y. pestis which helps it move through the immune system undetected to the lymph nodes before spreading to the rest of the body.
An extensive genetic analysis revealed that its copy number, or total number of pla genes found in the bacterium, had decreased in later outbreaks of the disease, which in turn decreased its mortality by 20% and increased the length of its infection, meaning the hosts lived longer before they died. These studies were performed in mice models of bubonic plague.
Conversely, when the pla gene was in its original, high copy number, the disease was much more virulent and killed each of its hosts and did so much quicker.

The scientists also identified a striking similarity between the trajectories of modern and ancient strains, which independently evolved similar reductions in pla in the later stages of the first and second pandemic, and so far, in three samples from the third pandemic, found in Vietnam today.
In both the Justinian and Black Death plagues, the evolutionary change occurred approximately 100 years after the first outbreaks. Scientists propose that when the gene copy number dropped and the infected rats lived longer, they could spread infection farther, ensuring the reproductive success of the pathogen.
“The reduction of pla may reflect the changing size and density of rodent and human populations,” explains Poinar. “It’s important to remember that the plague was an epidemic of rats, which were the drivers of epidemics and pandemics. Humans were accidental victims.”
Black rats in cities likely acted as “amplification hosts” due to their high numbers and proximity to humans. Because black rats are highly susceptible to Y. pestis, the pathogen needed rat populations to stay high enough to supply new hosts for Y. pestis to persist and allow the pandemic cycle to continue.
However, the pla-reduced strains eventually went extinct, likely reflecting another shift in the host-pathogen relationship within their environment.
When the researchers searched for signs of depletion in a large set of samples of the third pandemic preserved in a collection at the Institut Pasteur, they found three contemporary strains with pla depletion.
“Thanks to our international collaborators who monitor local epidemics of plague worldwide, we were able to find the unique bacterial samples used for this project, akin to finding three rare needles in a haystack,” says Javier Pizarro-Cerdá, co-senior author of the work, director of the Yersinia Research Unit and of the WHO Collaborating Center for Plague at the Institut Pasteur.
The institute houses one of the world’s richest collections of modern Y. pestis isolates, adds Guillem Mas Fiol, co-lead author of the study and postdoctoral researcher supervised by Pizarro-Cerdá.
“One of the most interesting aspects of our research was the possibility to explore a feature first observed in extinct plague strains, that could, for the first time, be experimentally tested in living contemporary bacterial strains,” he says.
“Although our research sheds light on an interesting pattern in the evolutionary history of plague, the majority of strains which continue to circulate today in Africa, South America and India are the more virulent ones, the ones that were previously responsible for massive mortality,” says Ravneet Sidhu, co-lead author of the study, and Ph.D. candidate at the McMaster Ancient DNA Center.
More information: Ravneet Kaur Sidhu et al, Attenuation of virulence in Yersinia pestis across three plague pandemics, Science (2025). DOI: 10.1126/science.adt3880. www.science.org/doi/10.1126/science.adt3880
Journal information: Science
 
News
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It [...]
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
Nanoplastics with environmental coatings can sneak past the skin’s defenses
Plastic is ubiquitous in the modern world, and it's notorious for taking a long time to completely break down in the environment - if it ever does. But even without breaking down completely, plastic [...]
Chernobyl scientists discover black fungus feeding on deadly radiation
It looks pretty sinister, but it might actually be incredibly helpful When reactor number four in Chernobyl exploded, it triggered the worst nuclear disaster in history, one which the surrounding area still has not [...]
Long COVID Is Taking A Silent Toll On Mental Health, Here’s What Experts Say
Months after recovering from COVID-19, many people continue to feel unwell. They speak of exhaustion that doesn’t fade, difficulty breathing, or an unsettling mental haze. What’s becoming increasingly clear is that recovery from the [...]
Study Delivers Cancer Drugs Directly to the Tumor Nucleus
A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles. CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to [...]
 
									















 
	 
	 
	 
	